Skip to main content
Reimbursement strategy

Cost-effective market access strategy for medical technologies in Europe

A holistic approach to reimbursement strategies trusted by global market leaders and SMEs

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

New version of the CCAM Nomenclature published in France

In mid-November 2024, a new version of the classification of procedure codes (CCAM v.77), effective from January 1, 2025, was published. 

No new codes were introduced. Changes concerned the tariff rules for procedures and their applications for doctors, including the integration of the Controlled Tariff Practice Option (OPTAM) ACO for anesthetists, the creation of three tariff grids, the creation of a new modifier, changes in modifiers, and the modification of tariffs for 31 dental procedures.

See the details in French here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.